Skip to content

Calcium Gluconate

DRUG19 trials

Sponsors

AstraZeneca AB, National Center for Research Resources (NCRR), Northwestern University, Alliance for Clinical Trials in Oncology, NCIC Clinical Trials Group

Conditions

ArthralgiaBlood Loss, PostoperativeBlood Loss, SurgicalBreast CancerChemotherapeutic Agent ToxicityColorectal CancerConotruncal Cardiac DefectsEsophageal Cancer

Early Phase 1

Phase 1

Phase 2

Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast Cancer
CompletedNCT00416715
University of WashingtonArthralgia, Musculoskeletal Complications, Pain +6
Start: 2006-10-31End: 2010-05-31Updated: 2017-07-11
Cabergoline Versus Calcium Gluconate Infusion in the Prevention of Ovarian Hyperstimulation Syndrome
CompletedNCT02875587
Aljazeera HospitalOHSS
Start: 2016-10-31End: 2018-12-31Updated: 2018-12-27
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
RecruitingNCT05958342
Jason SperryHemorrhage, Trauma
Start: 2024-06-30End: 2028-03-01Target: 1050Updated: 2026-03-16
A Phase IIb Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of Co-administration of AZD9550 and AZD6234 in Participants Living With Obesity or Overweight with Comorbidity
Active, not recruitingCTIS2024-516176-15-00
AstraZeneca ABInvestigating obesity or overweight condition correlated to many co-morbidities
Start: 2025-02-24Target: 40Updated: 2025-12-22
Calcium Administration in Life-saving Management During Massive Hemorrhage
Not yet recruitingNCT06820645
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sHypocalcemia, Massive Hemorrhage, Trauma
Start: 2025-05-01End: 2026-05-31Target: 81Updated: 2025-02-11
Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery in Pregnant Patients at High Risk for Uterine Atony
RecruitingNCT07217899
University of MichiganBlood Loss, Postoperative, Blood Loss, Surgical, Uterine Atony
Start: 2025-10-20End: 2026-08-31Target: 140Updated: 2025-10-29

Phase 3

Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation
TerminatedNCT00058188
Northwestern UniversityOsteoporosis, Prostate Cancer
Start: 2003-03-31End: 2008-11-30Updated: 2020-12-08
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity Caused By Oxaliplatin in Patients Receiving Combination Chemotherapy for Stage II, Stage III, or Stage IV Colorectal Cancer That Has Been Completely Removed By Surgery
CompletedNCT00316914
Alliance for Clinical Trials in OncologyColorectal Cancer, Neurotoxicity
Start: 2006-01-31End: 2012-11-30Updated: 2016-08-11
Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial
CompletedNCT00354302
NCIC Clinical Trials GroupBreast Cancer, Osteoporosis
Start: 2006-04-24End: 2012-01-06Updated: 2020-04-02
Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer
TerminatedNCT00998738
Mayo ClinicNeuropathy, Pain, Recurrent Breast Carcinoma +1
Start: 2009-11-30End: 2013-01-31Updated: 2016-02-04
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
CompletedNCT01099449
Alliance for Clinical Trials in OncologyChemotherapeutic Agent Toxicity, Colorectal Cancer, Neuropathy +1
Start: 2010-06-30End: 2013-03-31Updated: 2022-11-03
Cabergoline Versus Calcium Infusion in Ovarian Hyperstimulation Syndrome Prevention
CompletedNCT03473613
Benha UniversityOvarian Hyperstimulation
Start: 2014-10-01End: 2017-04-15Updated: 2018-03-29
Empiric Calcium in Massive Transfusion
WithdrawnNCT05953376
University of California, IrvineHemorrhage, Hypocalcemia, Shock, Hemorrhagic +1
Start: 2025-01-01End: 2026-12-01Updated: 2026-03-30

Phase 4

Unknown Phase

Related Papers